MFN Partners, LP 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-22 3:04 pm Sale | 2020-07-20 | 13G | Aclaris Therapeutics, Inc. ACRS | MFN Partners, LP | 1,895,677 4.530% | -2,104,323 (-52.61%) | Filing |